Béatrice Clemenceau INSERM, CNRS, Université d'Angers, Université de Nantes CRCINA Biography Publications Institution JoVE Articles Béatrice Clemenceau has not added a biography. If you are Béatrice Clemenceau and would like to personalize this page please email our Author Liaison for assistance. Publications GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR Frontiers in Immunology. 2018 | Pubmed ID: 29899740 Merkel Cell Carcinoma and Cellular Cytotoxicity: Sensitivity to Cellular Lysis and Screening for Potential Target Antigens Suitable for Antibody-dependent Cellular Cytotoxicity Cancer Immunology, Immunotherapy : CII. Aug, 2018 | Pubmed ID: 29808366 Impact on Early Outcomes and Immune Reconstitution of High-dose Post-transplant Cyclophosphamide Vs Anti-thymocyte Globulin After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Transplantation Oncotarget. Feb, 2018 | Pubmed ID: 29545911 The Doubling Potential of T Lymphocytes Allows Clinical-grade Production of a Bank of Genetically Modified Monoclonal T-cell Populations Cytotherapy. Mar, 2018 | Pubmed ID: 29396255 Adipose Cells Promote Resistance of Breast Cancer Cells to Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Breast Cancer Research : BCR. Apr, 2015 | Pubmed ID: 25908175 The Human Natural Killer Cytotoxic Cell Line NK-92, Once Armed with a Murine CD16 Receptor, Represents a Convenient Cellular Tool for the Screening of Mouse MAbs According to Their ADCC Potential MAbs. Jul-Aug, 2013 | Pubmed ID: 23770975 Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts Ulrich Jarry*1,2, Noémie Joalland*1,2, Cynthia Chauvin*1,2, Béatrice Clemenceau1,2,3, Claire Pecqueur1,2, Emmanuel Scotet1,2 1INSERM, CNRS, Université d'Angers, Université de Nantes, CRCINA, 2Immunotherapy, Graft, Oncology, LabEx IGO, 3Hopital de Nantes, Hotel Dieu JoVE 57870 Immunologia e infezioni
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts Ulrich Jarry*1,2, Noémie Joalland*1,2, Cynthia Chauvin*1,2, Béatrice Clemenceau1,2,3, Claire Pecqueur1,2, Emmanuel Scotet1,2 1INSERM, CNRS, Université d'Angers, Université de Nantes, CRCINA, 2Immunotherapy, Graft, Oncology, LabEx IGO, 3Hopital de Nantes, Hotel Dieu JoVE 57870 Immunologia e infezioni